High-dose-rate brachytherapy – a novel treatment approach for primary clear cell adenocarcinoma of male urethra
The incidence of male urethral cancer is rare with age preponderance of 50 to 60 years. The standard management approach is surgery. Here, we present a novel treatment approach for male urethral cancer. Thirty-six year old male, case of primary clear cell adenocarcinoma of urethra who refused surger...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Termedia Publishing House
2015
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4499518/ |